After four years as managing director of Danish pharmaceutical giant Novo Nordisk’s Algerian subsidiary, Malika de Maillard, born Malika Derghal, will be replaced on 1 July by Hamza Benharkat, who is currently the CFO of the firm’s Emirati subsidiary.
After four years as managing director of Danish pharmaceutical giant Novo Nordisk’s Algerian subsidiary, Malika de Maillard, born Malika Derghal, will be replaced on 1 July by Hamza Benharkat, who is currently the CFO of the firm’s Emirati subsidiary. Read More
